ESC 23 Late-Breaker Discussion: The ECLS-Shock Trial

Late-Breaker host, Harriette Van Spall (McMaster University, CA) is joined by Holger Thiele (Heart Center Leipzig at University of Leipzig, DE) to discuss the findings from the ECLS-SHOCK Trial.

The leading cause of death in hospitalised patients with acute myocardial infarction is cardiogenic shock. Efforts to improve outcomes for these patients has led to an increase in the use of mechanical circulatory support devices to attain haemodynamic stabilisation in severe cases of shock, especially the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO), also known as ECLS.

ECLS-SHOCK aimed to investigate the impact of ECLS on mortality in patients with acute myocardial infarction and cardiogenic shock. The results showed no reduction in 30-day mortality with early ECLS implementation, and an increase in complications, potentially leading to a discontinued use of these devices in clinical practice.

Recorded on-site at ESC Congress 2023, Amsterdam.

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/?...

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:   / radcliffecardiology  
Follow us on Twitter:   / radcliffecardio